Guo Lung Cancer 2020

Exploring Therapeutic Strategy against Mutations in Non-Small Cell Lung Cancer

‘Jessie’ Yanxiang Guo, PhD, has received a $1.7 million award from the National Institutes of Health to investigate the role of autophagy in the formation of tumors driven by mutations in tumor suppressors.

Exploring Autophagy as a Therapeutic Strategy against Frequent Mutations in Non-Small Cell Lung Cancer
Indian and Pakistani Women Diagnosed with More Aggressive Breast Cancer at Younger Age

Cancer of Unknown Primary (CUP)

(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-62509302-1', 'auto'); ga('send', 'pageview');

ASTRO 2020 Parikh

#ASTRO20: Studying Relapse Patterns in Pediatric Hodgkin Lymphoma

Rutgers Cancer Institute and Children’s Oncology Group researchers have determined response-based consolidation with modern radiation therapy is safe and effective in high-risk pediatric Hodgkin lymphoma patients.

Studying Patterns of Relapse in Pediatric Hodgkin Lymphoma using a Response-Based Therapy Approach

Center of Excellence in Cancer Immunology and Metabolism Leadership

.divTable{ display: table; width: 100%; } .divTableRow { display: table-row; } .divTableHeading { background-color: #EEE; display: table-header-group; } .divTableCell, .divTableHead { display: table-cell; padding: 3px 10px; height: auto; width: 50%; } .divTableBody { display: table-row-group; } .coe{ font: normal 24px Trebuchet MS,sans-serif; color: #cc0033; padding: 6px 0; }
Subscribe to